These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 35818814)

  • 1. Long-term prognosis of monoclonal immunoglobulin-associated glomerular diseases with non-organized deposits: A report of 38 cases from a Japanese single center.
    Nara M; Komatsuda A; Sawamura M; Abe F; Kaga H; Saito A; Saito M; Imaizumi C; Nanjo H; Wakui H; Takahashi N
    Clin Nephrol; 2022 Sep; 98(3):135-145. PubMed ID: 35818814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicopathological features and prognosis in immunoglobulin light and heavy chain deposition disease.
    Masai R; Wakui H; Togashi M; Maki N; Ohtani H; Komatsuda A; Sawada K
    Clin Nephrol; 2009 Jan; 71(1):9-20. PubMed ID: 19203545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful treatment with bortezomib and dexamethasone for proliferative glomerulonephritis with monoclonal IgG deposits in multiple myeloma: a case report.
    Noto R; Kamiura N; Ono Y; Tabata S; Hara S; Yokoi H; Yoshimoto A; Yanagita M
    BMC Nephrol; 2017 Apr; 18(1):127. PubMed ID: 28385149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A rare case of proliferative glomerulonephritis with monoclonal IgG2 kappa deposit: a case report.
    Ito D; Shiozaki Y; Shimizu Y; Suzuki Y; Takeda A; Misaki T
    BMC Nephrol; 2022 Dec; 23(1):396. PubMed ID: 36494791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A tale of monoclonal immunoglobulin: Clinicopathological analysis of proliferative glomerulonephritis with monoclonal immunoglobulin deposit.
    Maity P; Dasgupta S; Basu K; Sengupta M; Chowdhury AR; Bandopadhyay M
    Indian J Pathol Microbiol; 2021; 64(2):282-287. PubMed ID: 33851621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics of proliferative glomerulo-nephritis with monoclonal IgG deposits associated with membranoproliferative features.
    Masai R; Wakui H; Komatsuda A; Togashi M; Maki N; Ohtani H; Oyama Y; Sawada K
    Clin Nephrol; 2009 Jul; 72(1):46-54. PubMed ID: 19640387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proliferative glomerulonephritis with monoclonal immunoglobulin deposits: a nephrologist perspective.
    Bridoux F; Javaugue V; Nasr SH; Leung N
    Nephrol Dial Transplant; 2021 Jan; 36(2):208-215. PubMed ID: 33494099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Light chain only variant of proliferative glomerulonephritis with monoclonal immunoglobulin deposits is associated with a high detection rate of the pathogenic plasma cell clone.
    Nasr SH; Larsen CP; Sirac C; Theis JD; Domenger C; Chauvet S; Javaugue V; Hogan JJ; Said SM; Dasari S; Vrana JA; McPhail ED; Cornell LD; Vilaine E; Massy ZA; Boffa JJ; Buob D; Toussaint S; Guincestre T; Touchard G; D'Agati VD; Leung N; Bridoux F
    Kidney Int; 2020 Mar; 97(3):589-601. PubMed ID: 32001067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discordance of light chain isotypes between serum and glomerular deposits in proliferative glomerulonephritis with monoclonal IgG deposits: a case report and review of the literature.
    Miura S; Katayama K; Sugimoto Y; Tanaka F; Mori M; Takahashi D; Saiki R; Hirabayashi Y; Murata T; Tawara I; Dohi K
    BMC Nephrol; 2023 Jul; 24(1):199. PubMed ID: 37393252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A case of proliferative glomerulonephritis with monoclonal IgG deposits (PGNMID) that responded favorably to steroid therapy.
    Ogura Y; Yabushita S; Aihara H; Tsukada H; Hashiba T; Furuse S; Fujii A; Ueda Y; Mise N
    CEN Case Rep; 2022 May; 11(2):208-215. PubMed ID: 34628583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Poor outcomes of proliferative glomerulonephritis with monoclonal IgG deposits in renal allografts: a retrospective multicenter study.
    Wu Q; Liang D; Song T; Ni X; Wu X; Zhang M; Chen J; Cheng D; Xie K; Li X; Wen J
    J Nephrol; 2023 Jan; 36(1):93-101. PubMed ID: 35867238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Light chain only variant of proliferative glomerulonephritis with monoclonal immunoglobulin deposits: a clinicopathological study of three cases.
    Liang S; Liang D; Zhu X; Liang D; Xu F; Tu Y; Zeng C
    J Clin Pathol; 2024 Jul; 77(8):551-556. PubMed ID: 37137693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proliferative glomerulonephritis with monoclonal immunoglobulin deposits: an entity associated with distinct diseases and comparison between IgG1 and IgG3 subtypes.
    Liu M; Yu X; Wang S; Qin A; Zhou F; Zhao M
    J Nephrol; 2022 Dec; 35(9):2363-2372. PubMed ID: 35460458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recurrence of Proliferative Glomerulonephritis with Monoclonal Immunoglobulin G Deposits with a Striated Ultrastructure.
    Namba-Hamano T; Hamano T; Imamura R; Yamaguchi Y; Kyo M; Yonishi H; Takahashi A; Kawamura M; Nakazawa S; Kato T; Abe T; Kyakuno M; Takabatake Y; Nonomura N; Isaka Y
    Nephron; 2020; 144 Suppl 1():43-48. PubMed ID: 33227797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal monoclonal immunoglobulin deposition disease: the disease spectrum.
    Lin J; Markowitz GS; Valeri AM; Kambham N; Sherman WH; Appel GB; D'Agati VD
    J Am Soc Nephrol; 2001 Jul; 12(7):1482-1492. PubMed ID: 11423577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randall-type monoclonal immunoglobulin deposition disease: novel insights from a nationwide cohort study.
    Joly F; Cohen C; Javaugue V; Bender S; Belmouaz M; Arnulf B; Knebelmann B; Nouvier M; Audard V; Provot F; Gnemmi V; Nochy D; Goujon JM; Jaccard A; Touchard G; Fermand JP; Sirac C; Bridoux F
    Blood; 2019 Feb; 133(6):576-587. PubMed ID: 30578255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term renal survival of γ3-heavy chain deposition disease: a case report.
    Katsuno T; Mizuno S; Mabuchi M; Tsuboi N; Komatsuda A; Maruyama S
    BMC Nephrol; 2017 Jul; 18(1):239. PubMed ID: 28716013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment with bortezomib for recurrent proliferative glomerulonephritis with monoclonal IgG deposits in kidney allograft. Case report and review of the literature.
    Oki R; Unagami K; Taneda S; Takagi T; Ishida H
    J Nephrol; 2022 May; 35(4):1289-1293. PubMed ID: 35522429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progression of proliferative glomerulonephritis with monoclonal IgG deposits in pediatric patients.
    Miller P; Xiao AY; Kung VL; Sibley RK; Higgins JP; Kambham N; Charu V; Lenihan C; Uber AM; Talley EM; Arora N; Walavalkar V; Laszik ZG; Nast CC; Troxell ML
    Pediatr Nephrol; 2021 Apr; 36(4):927-937. PubMed ID: 33044675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A case of heavy-chain deposition disease with good long-term renal survival and a literature review.
    Cai X; Zou W; Chen H; Xing C; Yu X
    BMC Nephrol; 2024 Sep; 25(1):312. PubMed ID: 39300330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.